Related references
Note: Only part of the references are listed.Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?
Rolf Teschke et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Highlights of drug - and herb-induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
Omar Shahbaz et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study
Dieter Melchart et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem
Rolf Teschke et al.
ANNALS OF HEPATOLOGY (2016)
RUCAM in Drug and Herb Induced Liver Injury: The Update
Gaby Danan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature
Philip Sarges et al.
DRUG SAFETY (2016)
Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease
Rolf Teschke et al.
DRUG SAFETY (2016)
Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients
Yun Zhu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Clinical characteristics of drug-induced liver injury and related risk factors
Ren-Jie Lu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Hepatotoxicity by Drugs: The Most Common Implicated Agents
Einar S. Bjornsson
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges
Rolf Teschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife® products
Flavio Ailton Duque Zambrone et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Naga Chalasani et al.
GASTROENTEROLOGY (2015)
The Epidemiology of Cirrhosis in the United States A Population-based Study
Steven Scaglione et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset
Robert J. Fontana et al.
GASTROENTEROLOGY (2014)
The Global Burden of Liver Disease: The Major Impact of China
Fu-Sheng Wang et al.
HEPATOLOGY (2014)
An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data
T. Craig Cheetham et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Statins and the risk of liver injury: a population-based case-control study
Guan-Lin Chen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Epidemiology and Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Einar S. Bjornsson
SEMINARS IN LIVER DISEASE (2014)
Predicting idiosyncratic drug-induced liver injury - some recent advances
Minjun Chen et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
High Lipophilicity and High Daily Dose of Oral Medications Are Associated With Significant Risk for Drug-Induced Liver Injury
Minjun Chen et al.
HEPATOLOGY (2013)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
G. P. Aithal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury
Timothy J. Davern et al.
GASTROENTEROLOGY (2011)
Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
Einar Björnsson et al.
JOURNAL OF HEPATOLOGY (2011)
Important Elements for the Diagnosis of Drug-Induced Liver Injury
Vijay K. Agarwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Drug-Induced Liver Injury Network (DILIN) Prospective Study Rationale, Design and Conduct
Robert J. Fontana et al.
DRUG SAFETY (2009)
Epidemiology of Idiosyncratic Drug-Induced Liver Injury
Lauren N. Bell et al.
SEMINARS IN LIVER DISEASE (2009)
Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury
M. Garcia-Cortes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States
Naga Chalasani et al.
GASTROENTEROLOGY (2008)
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury
James Rochon et al.
HEPATOLOGY (2008)
The role of hepatitis E virus testing in drug-induced liver injury
H. R. Dalton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry
Raul J. Andrade et al.
HEPATOLOGY (2006)
Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic
M. B. De Valle et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Incidence of drug-induced hepatic injuries: A French population-based study
C Sgro et al.
HEPATOLOGY (2002)
Comparison of two clinical scales for causality assessment in hepatotoxicity
MA Lucena et al.
HEPATOLOGY (2001)
Share Paper
